Charles River (CRL) Forges Collaboration With Ship of Theseus
https://www.zacks.com/stock/news/2253832/charles-river-crl-forges-collaboration-with-ship-of-theseus?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2253832
Apr 11, 2024 - Charles River (CRL) is set to perform plasmid production for Ship of Theseus.
0
Catalent (CTLT) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
https://www.zacks.com/stock/news/2224065/catalent-ctlt-q2-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2224065
Feb 09, 2024 - Although the revenue and EPS for Catalent (CTLT) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
0
Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B
https://www.zacks.com/stock/news/2221276/novo-nordisk-nvo-to-acquire-3-catalent-sites-for-11b?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221276
Feb 05, 2024 - Novo Nordisk (NVO) will acquire Catalent's three manufacturing sites from Novo Holdings to expand its manufacturing capacity.
0